Burden, A.D., Okubo, Y., Zheng, M., Thaçi, D., van de Kerkhof, P., Hu, N., Quaresma, M., Thoma, C. and Choon, S. E. (2023) Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre-specified patient subgroups in the Effisayil 1 study. Experimental Dermatology, 32(8), pp. 1279-1283. (doi: 10.1111/exd.14824) (PMID:37140190)
Text
297834.pdf - Published Version Available under License Creative Commons Attribution. 1MB |
Abstract
Effisayil 1 was a multicentre, randomized, double‐blind, placebo‐controlled study of the anti‐interleukin (IL)‐36 receptor monoclonal antibody, spesolimab, in patients presenting with a generalized pustular psoriasis (GPP) flare. Previously published data from this study revealed that within 1 week, rapid pustular and skin clearance were observed in patients receiving spesolimab versus placebo. In this pre‐specified subgroup analysis, the efficacy of spesolimab was evaluated according to patient demographic and clinical characteristics at baseline in patients receiving spesolimab (n = 35) or placebo (n = 18) on Day 1. Efficacy was by assessed by achievement of primary endpoint (Generalized Pustular Psoriasis Physician Global Assessment [GPPGA] pustulation subscore of 0 at Week 1) and key secondary endpoint (GPPGA total score of 0 or 1 at Week 1). Safety was assessed at Week 1. Spesolimab was found to be efficacious and had a consistent and favourable safety profile in patients presenting with a GPP flare, regardless of patient demographics and clinical characteristics at baseline.
Item Type: | Articles |
---|---|
Additional Information: | The Effisayil 1 study was supported and funded by Boehringer Ingelheim. |
Keywords: | Autoinflammatory disorders, clinical trial, psoriasis. |
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Burden, Professor David |
Authors: | Burden, A.D., Okubo, Y., Zheng, M., Thaçi, D., van de Kerkhof, P., Hu, N., Quaresma, M., Thoma, C., and Choon, S. E. |
College/School: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity |
Journal Name: | Experimental Dermatology |
Publisher: | Wiley |
ISSN: | 0906-6705 |
ISSN (Online): | 1600-0625 |
Published Online: | 04 May 2023 |
Copyright Holders: | Copyright © 2023 The Authors |
First Published: | First published in Experimental Dermatology 32(8):1279-1283 |
Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record